Zenas Biopharma's Purchased 60,000: Insider Buy Deep Dive
A biotech CEO just bought a sizable chunk of his company’s stock. That move sparks questions about conviction, risk, ...
Elevate budgeting effectiveness by refining expense tracking, setting measurable goals, and reviewing progress regularly.
18,077 articlesA biotech CEO just bought a sizable chunk of his company’s stock. That move sparks questions about conviction, risk, ...
UnitedHealth stock quietly soared about 80% off its 2025 low, signaling a meaningful rebound. This article dives into...
Two global asset managers, two different paths to growth. This analysis pits BlackRock and Invesco against each other...
Vertical Aerospace just secured a pivotal supplier contract that could influence its production cadence and investor ...
A convicted fraudster charged with moving crypto from prison raises alarms over custody, enforcement, and blockchain ...
Ethereum isn't resting on its laurels. A bold plan for 2029 aims to streamline the network, cut costs, and attract bu...
A market correction tied to margin unwind can create a rare, patient-investor entry point. This article explains how ...
The beaten-down Figma shares rebound has investors weighing future growth, margins, and valuation. This guide breaks ...
A hedge fund's sizable exit from Protagonist Therapeutics highlights how insiders and funds shape biotech stock moves...
Sunrun’s stock tumbled on a day of mixed signals: strong quarterly revenue but cautious guidance for 2026. This artic...
February was brutal for some software names. This piece breaks down why monday.com stock lost february, what that sig...
Richtech Robotics faced a dramatic sell-off last month as legal issues and a disappointing earnings report rattled in...